COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/126058 |
Resumo: | Objetive: Bronchodilator delivery by means of metered-dose inhaler or intermittent nebulization is equivalent in the acute treatment of asthma. Some studies suggest that metereddose inhaler is less costly. The choice of the delivery method will depend on the consideration of costs. The aim of the present study is to compare the costs of aerosol bronchodilator delivery by use of an intermittent nebulizater versus metered-dose inhaler with valved spacer in patients with acute asthma in the adult emergency department.Methods: We compared the costs of different beta-adrenergic agents with and without ipratropium bromide delivered by intermittent nebulizer versus metered-dose inhaler with valved spacer in the adult emergency department of Hospital de Clínicas de Porto Alegre. Comparisons were made for 1, 6 and 12-hour treatment. The costs of all material used were taken into consideration.Results: The metered-dose inhaler with spacer was a less costly method of bronchodilator delivery in comparison to intermittent nebulization for the different beta-agonist agents, with and without ipratropium bromide.Conclusions: Bronchodilator delivery by means of a metered-dose inhaler with valved spacer was cost-saving in comparison to delivery by means of an intermittent nebulization in the treatment of acute asthma in the emergency department. The metered-dose inhaler/spacer treatment is progressively less expensive as the length of stay in the emergency department increases. |
id |
UFRGS-20_3ad7af49cc97d7bf9207f8cfb176c845 |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/126058 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACERESTUDO DE CUSTOS COMPARANDO DOIS MÉTODOS DE ADMINISTRAR O AEROSSOL BRONCODILATADOR NO TRATAMENTO DA ASMA AGUDA NA SALA DE EMERGÊNCIA: NEBULIZAÇÃO INTERMITENTE COM FLUXO DE AR COMPRIMIDO VERSUS SPRAY ACOPLADO A ESPAÇADOR VALVULADOEstudo de customedicina de emergênciatratamento da asma agudaespaçadornebulizadorCost studyemergency medicineacute asthma carenebulizerspacerObjetive: Bronchodilator delivery by means of metered-dose inhaler or intermittent nebulization is equivalent in the acute treatment of asthma. Some studies suggest that metereddose inhaler is less costly. The choice of the delivery method will depend on the consideration of costs. The aim of the present study is to compare the costs of aerosol bronchodilator delivery by use of an intermittent nebulizater versus metered-dose inhaler with valved spacer in patients with acute asthma in the adult emergency department.Methods: We compared the costs of different beta-adrenergic agents with and without ipratropium bromide delivered by intermittent nebulizer versus metered-dose inhaler with valved spacer in the adult emergency department of Hospital de Clínicas de Porto Alegre. Comparisons were made for 1, 6 and 12-hour treatment. The costs of all material used were taken into consideration.Results: The metered-dose inhaler with spacer was a less costly method of bronchodilator delivery in comparison to intermittent nebulization for the different beta-agonist agents, with and without ipratropium bromide.Conclusions: Bronchodilator delivery by means of a metered-dose inhaler with valved spacer was cost-saving in comparison to delivery by means of an intermittent nebulization in the treatment of acute asthma in the emergency department. The metered-dose inhaler/spacer treatment is progressively less expensive as the length of stay in the emergency department increases.Objetivo: A administração de broncodilatadores através de dispositivo com aerossol dosimetrado (spray) ou através de nebulizador é equivalente em eficácia no tratamento da asma aguda. Alguns estudos sugerem que o spray tem um custo menor. A escolha do método de administração do aerossol depende de considerações sobre o custo. O objetivo deste estudo é comparar os custos entre nebulização intermitente com fluxo de ar comprimido versus spray acoplado a espaçador valvulado na administração do aerossol broncodilatador no tratamento da asma aguda no setor de adultos da sala de emergência.Méotdo:s Comparamos os custos de diferentes agentes beta-adrenérgicos, com e sem brometo de ipratrópio, administrados por nebulização intermitente versus spray acoplado a espaçador valvulado no setor de adultos da emergência do Hospital de Clínicas de Porto Alegre. As comparações foram feitas para 1, 6 e 12 horas de tratamento. Foram considerados os custos de todos os materiais utilizados.Resutlados: O spray com espaçador consistiu em um método mais barato de administrar o broncodilatador em comparação com a nebulização intermitente para diferentes agentes beta-agonistas, com e sem ipratrópio.Conculsões: A administração do broncodilatador por spray com espaçador valvulado foi mais econômica em comparação à administração por nebulização intermitente no tratamento da asma aguda na sala de emergência. O tratamento com spray/espaçador é progressivamente mais barato à medida que o tempo de permanência no setor de emergência aumenta.HCPA/FAMED/UFRGS2022-07-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/126058Clinical & Biomedical Research; Vol. 22 No. 2 (2002): Revista HCPAClinical and Biomedical Research; v. 22 n. 2 (2002): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/126058/85616http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFranciscatto, Eduardo Kang, Suzie Piovesan, Deise Marcela Innocente, Cassiano Krost, Daniel Hoffmann, Cristine K. Fernandes, Andréia Mallmann, Felipe de T. R. Dalcin, Paulo 2022-09-16T16:34:14Zoai:seer.ufrgs.br:article/126058Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-09-16T16:34:14Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER ESTUDO DE CUSTOS COMPARANDO DOIS MÉTODOS DE ADMINISTRAR O AEROSSOL BRONCODILATADOR NO TRATAMENTO DA ASMA AGUDA NA SALA DE EMERGÊNCIA: NEBULIZAÇÃO INTERMITENTE COM FLUXO DE AR COMPRIMIDO VERSUS SPRAY ACOPLADO A ESPAÇADOR VALVULADO |
title |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER |
spellingShingle |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER Franciscatto, Eduardo Estudo de custo medicina de emergência tratamento da asma aguda espaçador nebulizador Cost study emergency medicine acute asthma care nebulizer spacer |
title_short |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER |
title_full |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER |
title_fullStr |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER |
title_full_unstemmed |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER |
title_sort |
COST COMPARISON OF TWO AEROSOL BRONCHODILATOR DELIVERY METHODS IN PATIENTS WITH ACUTE ASTHMA IN THE EMERGENCY DEPARTMENT: INTERMITTENT NEBULIZATION VERSUS METERED-DOSE INHALER WITH VALVED SPACER |
author |
Franciscatto, Eduardo |
author_facet |
Franciscatto, Eduardo Kang, Suzie Piovesan, Deise Marcela Innocente, Cassiano Krost, Daniel Hoffmann, Cristine K. Fernandes, Andréia Mallmann, Felipe de T. R. Dalcin, Paulo |
author_role |
author |
author2 |
Kang, Suzie Piovesan, Deise Marcela Innocente, Cassiano Krost, Daniel Hoffmann, Cristine K. Fernandes, Andréia Mallmann, Felipe de T. R. Dalcin, Paulo |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Franciscatto, Eduardo Kang, Suzie Piovesan, Deise Marcela Innocente, Cassiano Krost, Daniel Hoffmann, Cristine K. Fernandes, Andréia Mallmann, Felipe de T. R. Dalcin, Paulo |
dc.subject.por.fl_str_mv |
Estudo de custo medicina de emergência tratamento da asma aguda espaçador nebulizador Cost study emergency medicine acute asthma care nebulizer spacer |
topic |
Estudo de custo medicina de emergência tratamento da asma aguda espaçador nebulizador Cost study emergency medicine acute asthma care nebulizer spacer |
description |
Objetive: Bronchodilator delivery by means of metered-dose inhaler or intermittent nebulization is equivalent in the acute treatment of asthma. Some studies suggest that metereddose inhaler is less costly. The choice of the delivery method will depend on the consideration of costs. The aim of the present study is to compare the costs of aerosol bronchodilator delivery by use of an intermittent nebulizater versus metered-dose inhaler with valved spacer in patients with acute asthma in the adult emergency department.Methods: We compared the costs of different beta-adrenergic agents with and without ipratropium bromide delivered by intermittent nebulizer versus metered-dose inhaler with valved spacer in the adult emergency department of Hospital de Clínicas de Porto Alegre. Comparisons were made for 1, 6 and 12-hour treatment. The costs of all material used were taken into consideration.Results: The metered-dose inhaler with spacer was a less costly method of bronchodilator delivery in comparison to intermittent nebulization for the different beta-agonist agents, with and without ipratropium bromide.Conclusions: Bronchodilator delivery by means of a metered-dose inhaler with valved spacer was cost-saving in comparison to delivery by means of an intermittent nebulization in the treatment of acute asthma in the emergency department. The metered-dose inhaler/spacer treatment is progressively less expensive as the length of stay in the emergency department increases. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-07-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliado por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/126058 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/126058 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/126058/85616 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 22 No. 2 (2002): Revista HCPA Clinical and Biomedical Research; v. 22 n. 2 (2002): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767057514889216 |